Anvis Laboratories
+91 22 2830 2279

Anvis Laboratories Pvt. Ltd.

2/A-5, Priyadarshini, Poonam Nagar, Off Mahakali Road, Andheri East, Mumbai – 400 093, India

info@anvis-labratories.com

Anvis Laboratories
+91 22 2830 2279

Anvis Laboratories Pvt. Ltd.

2/A-5, Priyadarshini, Poonam Nagar, Off Mahakali Road, Andheri East, Mumbai – 400 093, India

info@anvis-labratories.com

Products Details

Redefining care through innovation. ANVIS empowers a healthier tomorrow with every solution we provide.
Anvis Labratories
Trusted Medicines, Better Lives

Dolan 30

Dolan 30 by ANVIS contains duloxetine 30 mg in delayed-release capsule form. Pack presentation: 1 × 10 capsules. Follow your prescription and do not stop treatment suddenly.

Info Product

Description

Dolan 30 is an ANVIS product labelled as duloxetine delayed-release capsules USP, 30 mg. The photographed carton contains one strip of ten capsules. This page identifies the ingredient, strength and release formulation and provides general information about duloxetine.

Dolan 30 product specification

  • Product name: Dolan 30
  • Active ingredient: Duloxetine
  • Labelled strength: 30 mg
  • Dosage form: Delayed-release capsules USP
  • Pack presentation: 1 strip × 10 capsules
  • Total quantity: 10 capsules
  • Brand: ANVIS

Match the full name, strength and capsule formulation to your prescription. The ten-capsule quantity is a pack detail. It does not tell you how often to take the medicine or how long treatment should continue. Ask a pharmacist to clarify any differences between the prescription and the supplied label.

General information about duloxetine

Duloxetine is a prescription antidepressant in the SNRI group. It is used for conditions including depression, anxiety and certain types of nerve pain. The reason for treatment and the appropriate dose require clinical assessment. Your own product leaflet should confirm the approved uses of this presentation.

Dolan 30: important safety information

Follow your prescription and swallow capsules whole as directed. Do not stop duloxetine suddenly: withdrawal symptoms can occur, and your doctor should guide any gradual reduction. Tell your clinician about other medicines and medical conditions before starting treatment.

Possible side effects include nausea, headache, dry mouth, dizziness, sleepiness and bowel changes. Avoid driving or machinery if dizzy or sleepy. Seek urgent medical help for a severe allergic reaction, thoughts of self-harm, or confusion with sweating, shaking and a fast heartbeat. These examples do not replace the complete leaflet.

Further information and enquiries

Read the NHS duloxetine guide for general ingredient information. For the full Dolan 30 specification, contact ANVIS and quote the 30 mg delayed-release capsule presentation. Alternatively, browse our capsule catalogue to identify other products.

Reviews

There are no reviews yet.

Be the first to review “Dolan 30”

Your email address will not be published. Required fields are marked *